David Garner
Chief Business Officer at Dopl Technologies
David Garner is Chief Business Officer at Dopl Technologies, CEO and Founder at RhinoCeros, and Co-Founder and Head of Operations at Venture Black. He previously co-founded CalmWave, which he has since left, and has held senior roles at Butterfly Network, General Motors, and HP. His expertise spans medtech innovation, executive leadership, operations, marketing, engineering, and angel investing.
Wink Therapeutics Wins Seattle Pitch Event, Gains $50K-$100K Investment for RNA-Based Type 1 Diabetes Therapy
Wink Therapeutics, a Miami-based RNA biotech startup focused on Type 1 diabetes, won first place and $50,000-$100,000 investment at a Seattle pitch event hosted by Venture Black. The company uses RNA therapeutics to restore pancreatic beta cells and was founded by biotech veteran Warren Marcus.
Organizations
See all 13-
Dopl Technologies Chief Business Officer 2024–present · current
-
Venture Black Co-Founder | Head of Operations 2024–present · current
-
RhinoCeros CEO, Founder 2017–present · current
Education
-
Carnegie Mellon University Bachelor of Science (B.S.), Mechanical Engineering, Engineering Design
-
MIT Sloan School of Management Management & Engineering
-
Milton
-
Carnegie Mellon University Bachelor of Science - BS, Mechanical Engineering
